Details
New companies 1 · Follow-on 0
Stages: Undisclosed 1
CMR Surgical ~$400M Strategic preferred equity agreementRanked by rounds participated in, from announcements in Sep 23, 2026 – Oct 22, 2026. Lead counts include only confirmed lead roles.
New companies 1 · Follow-on 0
Stages: Undisclosed 1
CMR Surgical ~$400M Strategic preferred equity agreementNew companies 1 · Follow-on 0
Stages: Undisclosed 1
Snappy Group Undisclosed Seven-figure venture debt facilityNew companies 1 · Follow-on 0
Stages: Series B 1
RadioNano Therapeutics Undisclosed Series B first closeNew companies 1 · Follow-on 0
Stages: Series B 1
RadioNano Therapeutics Undisclosed Series B first close“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.